Research Article

Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients

Table 1

Baseline demographics.

COVID-19 ICU patients (n = 103)Current treatment group (LMWH protocol) (n = 57)

Demographics
 Age (years)68.20 ± 11.3267.63 ± 12.65
 Gender (male/female)46/5730/27
 BMI (kg/m2)28.03 ± 5.1928.41 ± 5.20

Comorbidities
 Smoking5 (4.9%)0 (0.0%)
 Arterial hypertension62 (60.2%)33 (57.9%)
 Diabetes33 (32.0%)18 (31.6%)
 Respiratory disease20 (19.4%)8 (14.0%)
 Malignancy11 (10.7%)7 (12.3%)
 Chronic kidney disease15 (14.6%)9 (15.8%)
 Chronic liver disease3 (2.9%)2 (3.5%)
 Cardiovascular disease39 (37.9%)27 (47.4%)
 Chronic bowel disease8 (7.8%)4 (7.0%)
 Chronic nervous disease1 (1.0%)1 (1.8%)
 Cerebrovascular disease18 (17.5%)12 (21.1%)
 Haematological disease9 (8.7%)5 (8.8%)
 Rheumatological disease8 (7.8%)4 (7.0%)
 Dementia2 (1.9%)1 (1.8%)
 HIV/AIDS0 (0.0%)0 (0.0%)

Clinical data on admission
 Fever77 (74.8%)36 (63.2%)
 Cough82 (80.4%)39 (69.6%)
 Dyspnoea75 (73.5%)38 (67.9%)
 Sputum production11 (10.8%)6 (10.7%)
 Myalgia52 (51.0%)28 (50.0%)
 Headache10 (9.8%)4 (7.1%)
 Diarrhoea19 (18.6%)12 (21.4%)
 Respiratory rate25.11 ± 6.6626.00 ± 7.41
 Systolic blood pressure142.91 ± 26.70144.72 ± 25.97
 Diastolic blood pressure90.73 ± 17.1288.39 ± 14.29
 Heart rate88.44 ± 19.79
 Urine output day 11275.21 ± 822.001282.35 ± 726.99
 GCS (total)14.22 ± 1.3314.52 ± 1.16
 P/F ratio117.44 ± 78.95124.65 ± 61.48

Laboratory findings
 Red blood cell count (1012/l)4.09 ± 0.743.84 ± 0.74
 White blood cell count (109/l)8.77 ± 5.0810.89 ± 7.63
 Lymphocytes (%)19.91 ± 36.2829.45 ± 47.90
 Platelets (109/l)246.15 ± 101.72239.64 ± 100.24
 Bilirubin (mg/l)0.66 ± 0.590.72 ± 0.76

Length of stay (before ICU) (days)3.10 ± 5.123.95 ± 6.27
 SOFA (on ICU admission)4.52 ± 2.994.18 ± 2.51
 APACHE II (on ICU admission)12.49 ± 4.9411.96 ± 6.10
 APACHE IV (on ICU admission)46.21 ± 15.2442.61 ± 14.73
 Clinical frailty index4.01 ± 1.583.91 ± 1.65

Results are displayed in mean ± SD or as numbers (%).